{
 "about": "海外 VC、研究机构和公司画的女性健康市场图谱，每张打开原文核对过；g = 对应 layers.json 的 code，all = 全景。",
 "maps": [
  {
   "by": "CB Insights",
   "t": "The femtech market map",
   "d": "2024-03",
   "u": "https://www.cbinsights.com/research/femtech-womens-healthcare-market-map/",
   "img": "https://research-assets.cbinsights.com/2024/03/28170047/FemtechMMFIv2.png",
   "type": "research",
   "topic": "全景",
   "g": [
    "all"
   ],
   "cats": "199 家早期女性健康科技公司分 19 类，含虚拟与混合孕产护理、母胎筛查、盆底健康设备、联网吸奶器与穿戴、虚拟生育诊所、更年期等。",
   "note": "2023 年女性健康科技融资从 14 亿美元跌到 6.48 亿，但更年期科技与虚拟/混合护理逆势上涨；图里单列「联网吸奶器与穿戴」「盆底健康设备」，与我们的 f4、f5 直接对应。"
  },
  {
   "by": "FutureFemHealth",
   "who": "Anastasiya Markvarde",
   "t": "Women's health wearables 2026 report: A full-body map",
   "d": "2026-04",
   "u": "https://www.futurefemhealth.com/p/womens-health-wearables-2026-report",
   "img": "https://substack-post-media.s3.amazonaws.com/public/images/29c5f4b8-8c90-4194-86f8-ef24b70716a8_2048x1421.png",
   "type": "research",
   "topic": "可穿戴与硬件",
   "g": [
    "all"
   ],
   "cats": "按身体部位分 8 段：耳（智能耳环、耳部神经刺激）、头（神经刺激头带）、胸（智能文胸、围绝经期贴片）、腕与指（戒指、手环、大厂手表）、腹髋腰（痛经 TENS、骨密度）、盆底（智能月经杯、凯格尔、电刺激短裤）、孕期胎监与吸奶器、更年期降温手环。",
   "note": "和我们图谱最贴的一张：把 Oura、Apple、Garmin 等大厂与女性专属设备放进同一张图，主线是「从追踪走向治疗」；35+ 个设备，作者自己说不穷尽。"
  },
  {
   "by": "The XX Factor",
   "who": "Carolyn Witte",
   "t": "Is every company becoming a \"women's health\" company?",
   "d": "2025-03",
   "u": "https://thexxfactor.substack.com/p/is-every-company-becoming-a-womens",
   "img": "https://substack-post-media.s3.amazonaws.com/public/images/570f8c66-5408-4735-9409-874d88ae7568_3512x3102.png",
   "type": "research",
   "topic": "全景",
   "g": [
    "all"
   ],
   "cats": "四类：只做女性的、以女性为主的、并非只做女性的（含 Oura、Levels、WHOOP、Fitbit、Apple 等可穿戴）、卖给女性的（护老、儿科、男性生育）。",
   "note": "口径最宽：把 Oura 这类非女性专属公司也算女性健康公司，正文用 Oura 当案例，约 60% 用户是女性。作者是 Substack 通讯作者，不是机构。"
  },
  {
   "by": "Sunfish",
   "who": "Angela Rastegar",
   "t": "Start-ups and Technology Are Reshaping Fertility: 3 Trends to Watch at ASRM 2025",
   "d": "2025-10",
   "u": "https://www.joinsunfish.com/blogs-events/start-ups-and-technology-are-reshaping-fertility-3-trends-to-watch-at-asrm-2025",
   "img": "https://cdn.prod.website-files.com/682c4fe4f4a06f69ac9d550d/68e72e387f9afbd91f1efd6e_ASRM-MarketMap-LinkedInBlog-V4.png",
   "type": "company",
   "topic": "生育与周期",
   "g": [
    "f1"
   ],
   "cats": "约 250 家 ASRM 展会参展商：家庭建设服务方（诊所、药房、男性生育、捐卵代孕，占 25%）、财务可及、护理交付基础设施、使能技术（AI、冷冻存储、影像设备）、专业协会。",
   "note": "图名是「Who to Watch at ASRM: The Fertility Innovation Landscape 2025」，按展会参展名单画，偏 IVF 诊所与实验室，可穿戴很少；由生育金融公司 Sunfish 自己画。"
  },
  {
   "by": "Sunfish",
   "who": "Hope Durlofsky, Angela Rastegar",
   "t": "ASRM 2026: Fertility Tech's Next Opportunity Is Connecting Care",
   "d": "2026-10",
   "u": "https://www.joinsunfish.com/blogs-events/asrm-2026-fertility-techs-next-opportunity-is-connecting-care",
   "img": "https://cdn.prod.website-files.com/682c4fe4f4a06f69ac9d550d/6ada2633ed8dc3e64f35336a_IMG_9108.png",
   "type": "company",
   "topic": "生育与周期",
   "g": [
    "f1"
   ],
   "cats": "237 家 ASRM 2026 参展商分 22 个子类：财务保障、患者导航、诊所运营与 EMR、检测诊断、影像与设备、第三方生殖、护理交付、实验室与胚胎。",
   "note": "与 2025 版对比，窄功能的面向患者类收缩，实验室与诊所基础设施仍密；结论是生育科技从点解决方案走向平台。公司自己画。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "The Innovation Horizon for Pelvic Health",
   "d": "2026-08",
   "u": "https://www.femovate.com/horizon-maps/pelvic-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/6a6fa126ca872d1b5a1b9d18_Femtech%20Horizon%20Map%20Pelvic%20Health%20Q3%202026.png",
   "type": "research",
   "topic": "盆底与泌尿",
   "g": [
    "f5"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "图标 Q3 2026；涵盖凯格尔训练器、电刺激、子宫托、数字理疗等，页面指出这类公司连在广告里说出身体部位都受限。日期取图片上传月。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "The Innovation Horizon for Hormone Health",
   "d": "2026-04",
   "u": "https://www.femovate.com/horizon-maps/hormone-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/69e92c9ab19974d3f6c7df10_Femtech%20Horizon%20Map%20Hormone%20Health%202026%202x.png",
   "type": "research",
   "topic": "生育与周期",
   "g": [
    "f2",
    "f1"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "图标 Q2 2026；图中 Clair、Oura、Evie Ring、Lumia、Ultrahuman Ring 等带星号，表示只是用体温、HRV 等代理信号推断，不是直接测激素，对 f2 很有用。日期取图片上传月。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "The Innovation Horizon for Menopause",
   "d": "2025-05",
   "u": "https://www.femovate.com/horizon-maps/menopause-perimenopause",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/681c24d61bbe489dc048a495_Peri%20_%20Menopause%20-%20UPDATED.avif",
   "type": "research",
   "topic": "更年期与中年",
   "g": [
    "f6"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "页面写：大多数女性要在围绝经和绝经后度过人生的三分之一到一半。日期取该图（UPDATED 版，avif 格式）上传月，页面另有 2025-12 的补充图。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "Femtech Horizon Map: Breast Health",
   "d": "2026-02",
   "u": "https://www.femovate.com/horizon-maps/breast-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/699f5aea2dd220a65809b5fa_Femtech%20Horizon%20Map%20Breast%20Health%20Q1.jpg",
   "type": "research",
   "topic": "其他",
   "g": [
    "f7"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "图标 Q1 2026；含家用乳腺检查贴片、红外成像、AI 影像等筛查类设备，对应 f7。日期取图片上传月；页面无单独标题，标题按图名写。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "Menstrual Health: The Need for Better Solutions",
   "d": "2025-12",
   "u": "https://www.femovate.com/horizon-maps/menstrual-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/69348825fba28dfcdf8eca27_Menstrual%20Health%20-%20UPDATED.png",
   "type": "research",
   "topic": "生育与周期",
   "g": [
    "f1"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "页面开头：任何时候全球都有超过 25% 的人口在经期。日期取图片上传月。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "Uterine Health: The Need for Better Solutions",
   "d": "2025-12",
   "u": "https://www.femovate.com/horizon-maps/uterine-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/6933cb3069fb40540ca89991_Uterine%20Health%20-%20UPDATED.png",
   "type": "research",
   "topic": "其他",
   "g": [
    "f7"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "子宫肌瘤、子宫内膜相关；硬件含量不高，作为妇科筛查层的旁证。日期取图片上传月。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "Endometriosis: The Need for Better Solutions",
   "d": "2025-05",
   "u": "https://www.femovate.com/horizon-maps/endometriosis",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/681c2458bb57a8dbb448315a_ENDO%20-%20UPDATED.avif",
   "type": "research",
   "topic": "其他",
   "g": [
    "f7"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "页面开头写全球约 1.9 亿人患子宫内膜异位症。图为 UPDATED 版（avif 格式），日期取上传月；页面标题按页面首句写。"
  },
  {
   "by": "Femovate",
   "who": "Theresa Neil",
   "t": "The Innovation Horizon Maternal Mental Health",
   "d": "2025-12",
   "u": "https://www.femovate.com/horizon-maps/maternal-mental-health",
   "img": "https://cdn.prod.website-files.com/64c1e92bea4c096c4ef0842f/6933c99a69edf89081adb17b_Maternal%20Mental%20Health%20-%20UPDATED.jpg",
   "type": "research",
   "topic": "孕产与哺乳",
   "g": [
    "f3"
   ],
   "cats": "按临床需求四阶段（认知与教育、筛查与诊断、治疗与干预、维持与支持）摆放，再按证据等级分三档（专家意见、经科学评估验证、已获监管批准）。",
   "note": "孕产期心理健康，几乎全是软件与服务，硬件旁证用。日期取图片上传月。"
  },
  {
   "by": "Emmeline Ventures",
   "who": "La Keisha Landrum Pierre",
   "t": "The Hormonal Health Market: An Emmeline Ventures Map of the Hormonal Health Ecosystem",
   "d": "2026-04",
   "u": "https://www.linkedin.com/posts/lnlpierre_hormonal-health-research-activity-7451980524799045632-yMT1",
   "img": "https://media.licdn.com/dms/image/v2/D5622AQHsqJJDiZdWjg/feedshare-shrink_800/B56Z2rAy4sJoAc-/0/1776690605867?e=2147483647&v=beta&t=BwoG6nKABNLOT7JliNlm4iOk9J7vttI-dXsuaS-5YJM",
   "type": "vc",
   "topic": "生育与周期",
   "g": [
    "f2",
    "f1"
   ],
   "cats": "按融资阶段摆 logo：种子、Pre-seed、A/B/C/D 轮、上市、被收购、内部出资、未披露；底部按创始人性别汇总融资。",
   "note": "图上写总融资 218.5 亿美元（数据来自 Preqin 与 Tracxn），含 Mira、Oova 等家用激素检测；只发在 LinkedIn，图链接是领英图床，可能过期。"
  },
  {
   "by": "Emmeline Ventures",
   "who": "La Keisha Landrum Pierre",
   "t": "The Maternal Health Innovation Economy: A Market Map of the Maternal Health Innovation Economy",
   "d": "2026-09",
   "u": "https://www.linkedin.com/posts/lnlpierre_maternal-health-market-activity-7505611497444679680-KcNe",
   "img": "https://media.licdn.com/dms/image/v2/D5622AQHt_BGmpDFiSw/feedshare-shrink_800/B56aCiOsMwHUAg-/0/1789428155508?e=2147483647&v=beta&t=N9xCQA82n64KKSrI0W0GZCl6CbhfiWv4RV5NNiXntpk",
   "type": "vc",
   "topic": "孕产与哺乳",
   "g": [
    "f3",
    "f4"
   ],
   "cats": "按资金类型摆 logo：并购、天使、拨款、A/B 轮、早期 VC、后期 VC、孵化器、众筹。",
   "note": "图上写总融资 45.4 亿美元、总估值 94.1 亿；女性创始团队占公司数 59.14%，却占估值约 67.5%（作者原文）。只发在 LinkedIn，图链接可能过期。"
  },
  {
   "by": "Emmeline Ventures",
   "who": "La Keisha Landrum Pierre",
   "t": "Market Map of the Menopause Innovation Economy",
   "d": "2026-10",
   "u": "https://www.linkedin.com/posts/lnlpierre_menopause-awareness-month-activity-7520520120771862529-6mgS",
   "img": "https://media.licdn.com/dms/image/v2/D4E22AQFKjRXThzwNQg/feedshare-shrink_800/B4EaF5BMevG8Ac-/0/1793031719131?e=2147483647&v=beta&t=2iTiU_3esmWYsbBwQktqBeS-iBdzFTWy2hHG7kP9OMo",
   "type": "vc",
   "topic": "更年期与中年",
   "g": [
    "f6"
   ],
   "cats": "按融资阶段摆 logo：早期 VC、孵化器、后期 VC、并购、PE、拨款、公共资金、天使、未披露。",
   "note": "图上写总融资 38.1 亿美元、总估值 142.1 亿，女性创始公司占 59.6%；帖子称全球更年期市场 2033 年将达 288 亿美元。只发在 LinkedIn，图链接可能过期。"
  },
  {
   "by": "SJF Ventures",
   "t": "SJF Market Analysis Outlines Startups Disrupting Menopause Care, Opportunities for Investors",
   "d": "2023-06",
   "u": "https://sjfventures.com/sjf-ventures-market-analysis-outlines-startups-disrupting-menopause-care-and-opportunities-for-investors/",
   "img": "https://sjfventures.com/wp-content/uploads/2023/06/Menopause-landscape-1024x383.png",
   "type": "vc",
   "topic": "更年期与中年",
   "g": [
    "f6"
   ],
   "cats": "50 家公司分 5 类：生物制药、消费品、数字技术、医疗器械（Embr Labs、Mira、Amira 等）、虚拟与混合护理。",
   "note": "2015–2023 年第一季度累计约 5.3 亿美元；Embr Labs（降温手环）是唯一融到 D 轮的。较早的一张，可当更年期层的基线。"
  },
  {
   "by": "FemHealth Insights",
   "who": "Brittany Barreto 等",
   "t": "2023 FemTech Landscape Report",
   "d": "2024-03",
   "u": "https://www.femhealthinsights.com/s/Femtech_Landscape_Report_2023_FemHealthInsightspdf.pdf",
   "type": "research",
   "topic": "全景",
   "g": [
    "all"
   ],
   "cats": "按产品类型与健康垂直领域（月经、生育、孕产、更年期、心理健康、慢性病等）统计公司，并有按垂直放 logo 的页，另含退出与基金名录。",
   "note": "2024 年 3 月发布的 2023 年度报告，33 页 PDF；报告称约 85% 的创业公司至少有一位女性创始人。"
  },
  {
   "by": "Femtech France x Wavestone",
   "t": "Femtech Landscape Report 2026",
   "d": "2026-05",
   "u": "https://www.wavestone.com/wp-content/uploads/2026/05/2026-femtech-landscape-wavestone-x-femtech-france-en.pdf",
   "type": "research",
   "topic": "全景",
   "g": [
    "all"
   ],
   "cats": "法国 200 家 femtech 创业公司的地图与分类（含健康福祉占 39%），另有融资、医保报销、心理健康专题与全球对照。",
   "note": "只覆盖法国，但有一章把北欧与全球放在一起比较；59 页 PDF，地图在第 8 页。"
  },
  {
   "by": "FemTech Spain",
   "t": "FemTech Spain Market Map 2026",
   "d": "2026-09",
   "u": "https://www.femtechspain.es/en/ecosystem",
   "type": "research",
   "topic": "全景",
   "g": [
    "all"
   ],
   "cats": "西班牙 64 家活跃 femtech 公司，按类别、地区与技术类型分；约 1/3 是受监管技术。",
   "note": "与 Co-Salud、Digital Health Connector 合作，2025 年第一版是 50 家；只覆盖西班牙，58% 在巴塞罗那，页面是交互地图，没有静态图。"
  }
 ]
}